These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14724389)

  • 1. Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma.
    Rosenbluth J; Schiff R; Liang WL; Dou W
    J Neurocytol; 2003 Mar; 32(3):265-76. PubMed ID: 14724389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated CNS demyelination: focal spinal cord lesions induced by implantation of an IgM anti-galactocerebroside-secreting hybridoma.
    Rosenbluth J; Schiff R; Liang WL; Dou WK; Moon D
    J Neurocytol; 1999; 28(4-5):397-416. PubMed ID: 10739579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysmyelination induced in vitro by IgM antisulfatide and antigalactocerebroside monoclonal antibodies.
    Rosenbluth J; Moon D
    J Neurosci Res; 2003 Jan; 71(1):104-9. PubMed ID: 12478618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal cord dysmyelination induced in vivo by IgM antibodies to three different myelin glycolipids.
    Rosenbluth J; Liang WL; Schiff R; Dou WK
    Glia; 1997 Jan; 19(1):58-66. PubMed ID: 8989568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
    Mothe AJ; Tator CH
    Exp Neurol; 2008 Sep; 213(1):176-90. PubMed ID: 18586031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal cord dysmyelination caused by an antiproteolipid protein IgM antibody: implications for the mechanism of central nervous system myelin formation.
    Rosenbluth J; Schiff R
    J Neurosci Res; 2009 Mar; 87(4):956-63. PubMed ID: 18951490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype matching is not an essential requirement to achieve remyelination of demyelinating CNS lesions.
    Tepavcević V; Blakemore WF
    Glia; 2006 Dec; 54(8):880-90. PubMed ID: 17006890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration and remyelination by oligodendrocyte progenitor cells transplanted adjacent to focal areas of spinal cord inflammation.
    Wang Y; Piao JH; Larsen EC; Kondo Y; Duncan ID
    J Neurosci Res; 2011 Nov; 89(11):1737-46. PubMed ID: 21793039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of CNS myelin development in vivo by implantation of anti-GalC hybridoma cells.
    Rosenbluth J; Liu Z; Guo D; Schiff R
    J Neurocytol; 1994 Nov; 23(11):699-707. PubMed ID: 7861184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant human IgM promotes myelin repair after a single, very low dose.
    Warrington AE; Bieber AJ; Ciric B; Pease LR; Van Keulen V; Rodriguez M
    J Neurosci Res; 2007 Apr; 85(5):967-76. PubMed ID: 17304578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment.
    Wootla B; Watzlawik JO; Denic A; Rodriguez M
    Expert Rev Clin Immunol; 2013 Jun; 9(6):535-49. PubMed ID: 23730884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
    Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
    Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuregulin-1 promotes remyelination and fosters a pro-regenerative inflammatory response in focal demyelinating lesions of the spinal cord.
    Kataria H; Alizadeh A; Shahriary GM; Saboktakin Rizi S; Henrie R; Santhosh KT; Thliveris JA; Karimi-Abdolrezaee S
    Glia; 2018 Mar; 66(3):538-561. PubMed ID: 29148104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.
    Kotter MR; Setzu A; Sim FJ; Van Rooijen N; Franklin RJ
    Glia; 2001 Sep; 35(3):204-12. PubMed ID: 11494411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal cord injury is accompanied by chronic progressive demyelination.
    Totoiu MO; Keirstead HS
    J Comp Neurol; 2005 Jun; 486(4):373-83. PubMed ID: 15846782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of oligodendroglial progenitors in acute inflammatory demyelinating lesions of the rat brain stem is associated with demyelination rather than inflammation.
    Di Bello IC; Dawson MR; Levine JM; Reynolds R
    J Neurocytol; 1999; 28(4-5):365-81. PubMed ID: 10739577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
    Acs P; Komoly S
    Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelin regeneration in demyelinating disorders: new developments in biology and clinical pathology.
    Zawadzka M; Franklin RJ
    Curr Opin Neurol; 2007 Jun; 20(3):294-8. PubMed ID: 17495623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin.
    Wang C; Kotter MR
    Methods Mol Biol; 2018; 1791():233-241. PubMed ID: 30006714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.